Screener
Parabilis Medicines PBLS Q2 2026 earnings
Reported August 13, 2026 · Before market open
Revenue$100.0KMiss by $16.6M
EPS-$2.32Miss by $2.16
Revenue estimate$16.7M
EPS estimate-$0.17
Next report
Feb 11, 2027 (in 3 months)Revenue estimate$1.1M
EPS estimate-$0.42
Financials
Q2 2026Valuation & ratios
Versus estimates
Revenue
Q3 2026$2.1MBeat by $1.7M
Q2 2026$100.0KMiss by $16.6M
Diluted EPS
Q3 2026-$0.36In line
Q2 2026-$2.32Miss by $2.16
FAQ
- When did Parabilis Medicines report Q2 2026 earnings?
- Parabilis Medicines (PBLS) reported Q2 2026 earnings on August 13, 2026 before market open.
- What were Parabilis Medicines's Q2 2026 revenue and EPS?
- Parabilis Medicines reported revenue of $100.0K and eps of $-2.32 for Q2 2026.
- Did Parabilis Medicines beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $16.7M by $16.6M. EPS missed the consensus estimate of $-0.17 by $2.15.
- Where can I find Parabilis Medicines's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-347869) and the 10-Q periodic report (0001193125-26-349168) directly on SEC EDGAR. The filing index links above go to sec.gov.
